Amunix Pharmaceuticals, Inc.
9Patents
9Active
9Granted
48Portfolio score
Filing activity: Aug 26, 2016 → Feb 25, 2025
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10953073B2 | XTEN conjugate compositions and methods of making same | Chemistry; Metallurgy | 5 | Active |
| US10961287B2 | Extended recombinant polypeptides and compositions comprising same | Chemistry; Metallurgy | 4 | Active |
| US11713358B2 | Chimeric polypeptide assembly and methods of making and using the same | Chemistry; Metallurgy | 3 | Active |
| US10870874B2 | Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same | Chemistry; Metallurgy | 3 | Active |
| US12060424B2 | Release segments and binding compositions comprising same | Chemistry; Metallurgy | 0 | Active |
| US11981744B2 | Chimeric polypeptide assembly and methods of making and using the same | Chemistry; Metallurgy | 0 | Active |
| US12215156B2 | HER-2 targeted bispecific compositions and methods for making and using the same | Chemistry; Metallurgy | 0 | Active |
| US12428494B2 | Compositions targeting prostate-specific membrane antigen and methods for making and using the same | Chemistry; Metallurgy | 0 | Active |
| US12071456B2 | Extended recombinant polypeptides and compositions comprising same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.